Speeches

Lord Freyberg – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Lord Freyberg on 2016-01-13.

To ask Her Majesty’s Government what information (1) the National Cancer Intelligence Network, (2) Public Health England, (3) the National Institute for Health Research, and (4) the NHS more broadly, hold on mesothelioma and other less common cancers covering (a) hospital surgical volumes; (b) hospital systemic anti-cancer treatment volumes; (c) hospital radiotherapy volumes; (d) clinical trial volumes by hospital; (e) cancer stage and grade at presentation; (f) short-term patient outcomes; (g) one-year survival rates; and (h) five-year survival rates.

Lord Prior of Brampton

The National Cancer Registration Service and National Cancer Intelligence Network are both part of Public Health England and collect data on all diagnoses of cancer in England, including mesothelioma and other rare cancers.

Data on one-year survival from mesothelioma have been published and is attached. The relative survival for men at one year was 34%; varying between 27% and 39% across England. The relative survival for women at one year was 40%; varying between 24% and 70% across England.

Data on hospital surgical volumes; hospital systemic anti-cancer treatment volumes; hospital radiotherapy volumes; clinical trial volumes by hospital; cancer stage and grade at presentation; short-term patient outcomes; and five-year survival rates are not held in the format requested.

Data on whether patients have been offered/entered into a clinical trial is now mandated as part of the Cancer Outcomes and Services Dataset, so we anticipate being able to report on this in the future.

Within the current financial year, the National Institute for Health Research (NIHR) Clinical Research Network has recruited up to 80 trials in less common cancers in a total of 124 recruitment sites. Details of the trials recruiting at each site are in the attached table, Trials in less common cancers in portfolio of NIHR Clinical Research Network. The NIHR does not collect information on hospital surgical volumes; hospital systemic anti-cancer treatment volumes; hospital radiotherapy volumes; cancer stage and grade at presentation; short-term patient outcomes; one-year survival rates; and five-year survival rates.

With regard to National Health Service more broadly, NHS England has advised that it does not hold the information requested.